Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1396 AL 1410

A brief overview of amyloids and Alzheimer's disease

Ow SY, Dunstan DE.

Protein Sci. 2014 Oct;23(10):1315-31. doi: 10.1002/pro.2524. Epub 2014 Jul 30.

Effects of external cues on gait parameters of Parkinson's disease patients: a systematic review

Rocha PA, Porfírio GM, Ferraz HB, Trevisani VF.

Clin Neurol Neurosurg. 2014 Sep;124:127-34. doi: 10.1016/j.clineuro.2014.06.026. Epub 2014 Jul 5.

Peripheral alpha-synuclein and Parkinson's disease

Olanow CW, Wakeman DR, Kordower JH.

Mov Disord. 2014 Jul;29(8):963-6. doi: 10.1002/mds.25966.

The clinical spectrum of anxiety in Parkinson's disease

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ.

Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937.

Living and dying with Parkinson's disease

Ross GW, Abbott RD.

Mov Disord. 2014 Nov;29(13):1571-3. doi: 10.1002/mds.25955. Epub 2014 Jul 7.

Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

Borgohain R, Szasz J, Stanzione P, Meshram C, Bhatt MH, Chirilineau D, Stocchi F, Lucini V, Giuliani R, Forrest E, Rice P, Anand R; Study 018 Investigators.

Mov Disord. 2014 Sep;29(10):1273-80. doi: 10.1002/mds.25961. Epub 2014 Jul 10.

Tai Chi for improvement of motor function, balance and gait in Parkinson's disease: a systematic review and meta-analysis

Yang Y, Li XY, Gong L, Zhu YL, Hao YL.

PLoS One. 2014 Jul 21;9(7):e102942. doi: 10.1371/journal.pone.0102942. eCollection 2014.

Evidence of inflammatory system involvement in Parkinson's disease

Chao Y, Wong SC, Tan EK.

Biomed Res Int. 2014;2014:308654. doi: 10.1155/2014/308654. Epub 2014 Jun 24.

Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry

Kellie JF, Higgs RE, Ryder JW, Major A, Beach TG, Adler CH, Merchant K, Knierman MD.

Sci Rep. 2014 Jul 23;4:5797. doi: 10.1038/srep05797.

Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients

Pappone C, Vicedomini G, Manguso F, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Tavazzi L, Santinelli V.

Circulation. 2014 Sep 2;130(10):811-9. doi: 10.1161/CIRCULATIONAHA.114.011154. Epub 2014 Jul 22.

The asymptomatic Wolff-Parkinson-White patient: time to be more proactive?

Obeyesekere MN, Klein GJ.

Circulation. 2014 Sep 2;130(10):805-7. doi: 10.1161/CIRCULATIONAHA.114.011856. Epub 2014 Jul 22.

Cognitive reserve in stroke and traumatic brain injury patients

Nunnari D, Bramanti P, Marino S.

Neurol Sci. 2014 Oct;35(10):1513-8. doi: 10.1007/s10072-014-1897-z. Epub 2014 Jul 23.

Management of anxiety and motor symptoms in Parkinson's disease

Coakeley S, Martens KE, Almeida QJ.

Expert Rev Neurother. 2014 Aug;14(8):937-46. doi: 10.1586/14737175.2014.936388.

Dopaminergic modulation of striatal networks in health and Parkinson's disease

Surmeier DJ, Graves SM, Shen W.

Curr Opin Neurobiol. 2014 Dec;29:109-17. doi: 10.1016/j.conb.2014.07.008. Epub 2014 Jul 22.

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

Schoedel KA, Morrow SA, Sellers EM.

Neuropsychiatr Dis Treat. 2014 Jun 26;10:1161-74. doi: 10.2147/NDT.S30713. eCollection 2014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias